NanoViricides Says NV-387 Antiviral Drug Could Help Reduce Metastatic Cancer Resurgence-March 2024-www.financetom.com

NanoViricides Says NV-387 Antiviral Drug Could Help Reduce Metastatic Cancer Resurgence

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

NanoViricides Says NV-387 Antiviral Drug Could Help Reduce Metastatic Cancer Resurgence

Aug 18, 2025 6:23 AM

09:04 AM EDT, 08/18/2025 (MT Newswires) -- NanoViricides ( NNVC ) said Monday its NV-387 antiviral drug could help lower resurgence of metastatic cancer caused by awakening of "sleeping" cancer cells due to viral infections.

The biopharmaceutical company said the drug is being advanced into phase II trials following completion of a phase I trial.

Shares were up 2% in recent premarket activity.

Previous page： US FDA expands use of Amgen, AstraZeneca's drug for sinus infection Next page： Oracle's Long-Term Outlook Likely Disappointed Some Investors, UBS Says

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

US FDA expands use of Amgen, AstraZeneca's drug for sinus infection

Oct 17, 2025

Oct 17 (Reuters) - The U.S. Food and Drug Administration has approved Amgen ( AMGN ) and AstraZeneca's ( AZN ) drug for a type of chronic sinus infection, the drugmakers said on Friday. ...

Oracle's Long-Term Outlook Likely Disappointed Some Investors, UBS Says

Oct 17, 2025

04:12 PM EDT, 10/17/2025 (MT Newswires) -- Oracle's (ORCL) long-term outlook may have disappointed some investors, but there are reasons to own the cloud computing company's stock, UBS Securities said in a Friday note. Shares of Oracle declined 6.9% on Friday after the company said on Thursday it was aiming for earnings of $21 per share by fiscal 2030 and...

Northeast Recovery LLC Announces Acquisition of Collateral from Ark National Holdings LLC Pursuant to UCC 9-620

Oct 17, 2025

QUINCY, Mass., Oct. 17, 2025 /PRNewswire/ -- Northeast Recovery LLC (Northeast Recovery) today announced that it has completed a debt-for-assets transaction with Ark National Holdings LLC (Ark Behavioral Health), a leading provider of clinical, medical, and psychiatric care for substance use, mental health, and co-occurring disorders in Massachusetts. Pursuant to the transaction, consummated pursuant to Section 9-620 of the Uniform...

BRIEF-US FTC Says It Approves Final Divestiture Order In Synopsys And Ansys Deal

Oct 17, 2025

Oct 17 (Reuters) - * U.S. FTC SAYS IT APPROVES FINAL DIVESTITURE ORDER IN SYNOPSYS AND ANSYS DEAL * U.S. FTC SAYS IT APPROVES FINAL DIVESTITURE ORDER IN SYNOPSYS AND ANSYS DEAL Source text: https://www.ftc.gov/news-events/news/press-releases/2025/10/ftc-approves-final-divestiture-order-synopsys-ansys-deal Further company coverage: ...